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Chapter 1  
Introduction 
 
1.1 Background 
In today’s modern operating room, care of the surgical patient during an operation is              
provided by a team of individuals referred to as the care team. The care team monitors                
the patient’s physiological status by regularly checking the vital signs on display            
monitors and other devices. Usually, the care process requires balancing administration           
the appropriate amounts of intravenous fluids and drugs, often employing infusion           
pumps whose parameters may be manually adjusted to keep the patient’s vital signs at              
desired levels. During complex surgical procedures, more fluids are required. This           
necessitates the simultaneous use of multiple pumps and, in most cases, these pumps             
differ in purpose and monitored parameters. Further, utilization of multiple pumps can            
prove to be cumbersome, requiring meticulous attention to input parameters to avoid            
fatal medical errors. 
To assist the team in such circumstances, we are designing and developing a             
proof-of-concept computer-based system also known as a closed-loop assistant (CLA).          
This system will handle all communication and connections between devices and           
evaluate data obtained from monitoring equipment. The system will also process the            
collected data and execute changes to the infusion pump parameters in order to let the               
care team concentrate on other tasks. A conceptual picture of the CLA is shown in               
Figure 1.1.  
The focus of this thesis was on testing and validating systems like the CLA. Without               
proper testing and validation tools, it is very difficult to design a CLA that is safe and                 
effective for use with patients. 
1.2 Motivation 
Since the care team will rely upon the stability of the CLA throughout the patient’s               
surgery experience, it is crucial that the CLA is accurate to ensure the safety of the                
patient and success of the surgery. The CLA should have the ability to perform              
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fundamental tasks such as informing the team of technical glitches like lost connection             
to other devices. It should also be able to yield control to teams in similar situations. 
 
Figure 1.1.​ CLA concept 
Patient safety being a major concern, methods for verifying and validating the CLA, in              
order to guarantee reliability, need to be developed. In addition, there should be a way               
to confirm that the designed system meets its original specifications. One way to do this               
would be to perform human trials but this process is complicated, potentially            
hazardous, not reproducible, and expensive. Thus, human trials necessitate intricate          
safety precautions. Animal studies are only somewhat easier, having similar limitations.           
Furthermore, performing repeatable physiological trials to evaluate design        
modifications is functionally impossible. 
Models have been used before in this process. For example, in the study of glucose               
regulation in patients with type 1 diabetes, ​in silico patients have been developed and              
used to provide a basis for testing as well as optimization of diabetes treatment [1]–[5].               
The same technique has been used to verify the safety properties of a closed loop               
system which consists of the heart and a pacemaker [6]–[8]. Therefore, to achieve the              
desired test coverage without worrying about test failures that can harm patients, we             
have to design a software patient model that simulates human physiology. 
For more realistic testing, this patient model can be connected to the rest of our system                
through a physical simulator that generates and sends signals to the monitoring            
devices. The patient model is designed to mimic human dynamics and responses and             
therefore can be used to test our system in a closed loop. By mimicking the behavior of                 
the environment in which the CLA is expected to be used, the ​in silico model will allow                 
us to validate the CLA’s performance by testing the software algorithm that controls the              
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CLA and observe its interactions with the rest of the system. Consequently, we will              
learn the response of the model to variations in the CLA’s parameters. Having such a               
model will enhance safety by allowing us perform potentially dangerous tests in a             
virtual environment. 
1.3 Research Objectives 
My research broadly focused on developing tools for testing systems like the CLA. Such              
tools are critical to the development of CLA technologies. Figure 2 shows the             
conceptual picture of the CLA as well as the identified key enabling science and              
technologies. The patient models mentioned previously as critical to testing CLA           
interaction with patient physiology is indicated as T1. The intelligent algorithms and            
the platform on which they run which connect them to the various medical devices are               
labeled as T2 and T3 respectively. For this thesis we did not focus on the interaction                
between the CLA and the care team (T4), though this is important for full CLA               
validation.  
 
Figure 2.​ The CLA concept with enabling science and technologies highlighted. 
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Due to the distributed architecture, networking equipment, and interactions between          
cross-vendor devices present in the CLA, there is uncertainty in the system behavior.             
Testing allows to address this uncertainty because it facilitates the detection of defects             
and evaluation of system performance before deployment. 
The two main objectives of my thesis were: 
1. Develop pure software simulation of CLA-patient interaction to provide early          
insights into potential CLA behavior (​Chapter 3​) 
2. Develop a framework for connecting a virtual patient model (T1) with a CLA (T2              
and T3) consisting of real medical devices to facilitate realistic real-time,           
system-in-the-loop testing of CLA to complement the results obtained for pure           
software simulations in the first objective (​Chapter 4​). 
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Chapter 2 
Background and Literature Review 
 
2.1 Closed-Loop Systems in Medicine 
One of the more well-known closed-loop system used in medicine is the pacemaker. It              
is a device that is implanted underneath the skin that senses the activity of heart (and                
sometimes other factors), and sends electrical signals to slow or increase the heart rate              
[9], [10]. A more recent system is the artificial pancreas [11], [12] used in the               
management of type 1 diabetes [13]. It consists of a continuous glucose monitor and an               
insulin pump, and algorithm (either implemented on the pump or separate device), that             
monitors the blood glucose and adjusts the insulin infusions based on this sensed             
information. These two systems share some similarities. In both cases the patient            
condition is chronic (or permanent). The devices compensate for lost function in the             
body. Both these systems are also used by the patient outside the clinical environment              
and provide care that enhance the quality of life for the patient. 
There are closed-loop systems that are used in the clinical environment as well. Patients              
during surgery or in the intensive care unit (ICU) sometimes temporarily lose the ability              
to control their blood glucose properly. There is a commercial available           
computer-system called Glucommander [14]. [15] that directs clinicians on how to           
adjust insulin infusion based on the glucose test results input to the computer by the               
clinician. Although this can be described as more of a decision support system, the              
system can also be considered closed-loop because it decides on the infusion. There is              
also recent work in closed-loop management of fluids [16], [17], blood pressure [18],             
and anesthetics [19] during surgery. These systems are examples of the closed-loop            
assistant (CLA) technology that is the focus of this thesis. They focus on treatment of               
specific conditions that are temporary and are used under the supervision of clinicians             
in the clinical environment. In addition, CLAs have to deal with more complex             
physiological conditions since there can be multiple simultaneous treatment actions          
going on.  
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2.2 Testing of Closed-Loop Medical Systems 
At different phases of development, closed-loop systems undergo various tests. Early in            
development, simulation is used to validate ideas and algorithms. When a feasible            
prototype is developed, pre-clinical trials using animals is usually undertaken. At later            
stages in the development various phases of human trials would be conducted [20].  
However, not all closed-loop systems may go through all these phases. Where the             
closed-loop system can start out as a decision support system, animal trials are             
sometimes skipped altogether. The Glocummander systems [14] seems to have started           
off this way as an automation of an already existing clinical protocol. In this case the                
system functions as a decision support suggesting the new infusion but leaving the             
option of whether to follow that suggestion or do something else to the clinician who               
then implements whatever decision was taken.  
For the diabetes case, a simulator was developed that was eventually approved as an              
alternative to animal trials [1], [4].  
2.3 Testing of Medical Devices Using Simulations 
As mentioned previously, simulations are typically used earlier in the development           
process to test and validate algorithm ideas. Recently, however, there has been interest             
in leveraging simulations for testing much later in the design and development process.             
The diabetes case, where the simulator has a patient population in addition to realistic              
models of the medical devices involved is one example. The pacemaker verification case             
mentioned earlier is another example. In that work, a hardware version of the virtual              
heart model that can interact with real pacemakers was developed [21]. The ability to              
run a test of a prototype of the real medical system with a simulated patient is typically                 
called ​in silico​ testing.  
There is recent interest by the FDA in ​in silico testing as part of the evidence provided to                  
support the safety and efficacy claims made for closed-loop systems [22]. A recent             
paper by FDA authors reviewed the use of simulations in testing various closed-loop             
systems and offered suggestions on ways in which these simulations could be used to              
support device claims, focusing on the validity of the simulation results [23]. 
The work in this thesis is aimed at provide such testing capabilities for CLAs at the later                 
stages of the design process in the hopes that this could help with safety and efficacy                
analysis of these devices for the regulatory process.  
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Chapter 3 
Software Simulation of CLA-Patient 
Interactions  1
 
3.1 Motivation 
The most ideal controllable and repeatable testing scenario for a CLA is with real              
devices interacting with a realistic patient model. Pure software simulations, however,           
provide a lower overhead but useful environment in which to explore early designs.             
Because pure software simulations ran much faster than real-time, many scenarios can            
be explored quickly. Even in pure software simulation, some non-idealities in system            
behavior can be represented giving faster insights into potential issues and allowing for             
improving early concept designs before committing to hardware and software that is            
closer to the final product, which is also more expensive to iterate on. This chapter               
focuses on a software framework we developed that allows for quicker early            
explorations to complement the higher-fidelity real-time framework.  
3.2 Architecture Overview and Design 
A conceptual representation for the framework is shown in Figure 3.1. It is comprised of               
models of medical devices such as monitors and infusion pumps, a physiology            
management algorithm, and a patient physiology model. The monitor models the           
interaction with the patient to derive vital signs that are reported periodically to the              
algorithm. The pump models taking instructions from the algorithm and turning them            
into infusion actions which results in fluids or drugs entering the patient at a particular               
rate. The algorithm models software that receives data periodically for the monitors,            
decides on actions (or inactions) based on this data and then instructs the pump on the                
rate of infusion of various fluids or drugs. Although the platform that enables             
connectivity between the devices and the algorithm and also runs the algorithm is not              
shown explicitly, the communication between the different parts are modeled and           
real-world issues like loss of data and delays are captured in a conceptual manner. 
1 Most of the information in this chapter is reproduced from [24], which we presented at the 2018                  
Medical Cyber-Physical Systems Workshop in,Porto, Portugal 
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Figure 3.1.​ Conceptual architecture of software simulation framework for CLA-patient interactions 
In spite of the fact that a only single a physiology management algorithm is              
demonstrated in Figure 3.1, the framework is capable of handling interactions between            
devices and several algorithms (with the potential for algorithms to interact with each             
other). In addition, variations in any part of the architecture (patient, devices,            
algorithm(s)) can be explored. The exploration of variations of such scenarios is            
facilitated by the modular architecture of the key components of the framework. For             
example, given a particular patient, we were able to explore the impact of various              
renditions of the CLA. This can be achieved by changing either the devices or              
algorithm, or their parameters. Likewise, we can also explore interactions between a            
particular CLA instance with different patients. This allows us to undertake a design             
space exploration using a patient population instead of a single patient model. The use              
of the patient population allows us to understand how robust a particular design is to               
inter-patient variability. This can also allow us to begin to see the potential safety level               
of our early concept design using some of the techniques developed in [25]. The              
conceptual picture of this design space exploration is shown in Figure 3.2. 
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Figure 3.2.​  Conceptual diagram showing the design space exploration using in-silico patient 
models 
3.3 Implementation 
The software simulation framework is implemented using the Pulse Physiology          
Platform [26], an open-source physiology platform based on well-validated models that           
provides a software development kit (SDK) for interacting with the physiology models            
that allow you to control and extract patient state, and present inputs to the patient (e.g.                
infusion of fluids, or consumption of meals). We build our framework by developing             
models of monitors, pumps, algorithms, and the connections between these, and           
leveraged the Pulse SDK to connect the relevant parts to Pulse and to control to the                
overall simulation.  
3.3.1 Pulse Physiology Engine 
One of the main objectives of the Pulse Physiology Platform is to aid in the design,                
development and the adoption of physiologic modeling. Through the creation of a            
modular and extensible ontology for the simulation of human physiology, Pulse can            
speed up model development and also simplify integration with third party (for both             
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hardware testing and software simulation). To facilitate its integration, the Pulse           
platform comprises a Common Data Model (CDM), a software framework, and the            
Pulse Physiology Engine, as indicated in figure 3.3. Pulse has been used in a number of                
medical simulations (e.g. [27], [28]), has a sizeable user community, and is developed by              
a company known for delivering quality open-source tools useful for medical and other             
applications. These reasons make it a good choice for software on which on our              
framework is based.  
 
Figure 3.3.​ ​Pulse Physiology Platform software architecture. 
3.3.1.1 Physiology Models 
This engine is built on top of various abstract models (model architecture illustrated in              
Figure 3.4), that are used to simulate the feedback mechanisms and interactions            
between the systems, pharmacodynamics/pharmacokinetics (PD/PK) and the medical        
equipments like the anesthesia machine. These models are meant to represent the            
different systems of the body.  
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The particular systems of the body consist of numerical models which use of circuit              
analogues (like capacitors and resistors) to approximate behavior of a region of interest             
or even system of the entire body. 
 
Figure 3.4.​ Pulse Physiology Engine model architecture. 
The PK model symbolizes substance movement, particularly the movement of drugs           
through the whole body by means of clearance and diffusion focusing on the plasma              
concentration after a period of time. The moment the plasma concentration has been             
calculated accurately, the drug effects or even the PD effects on the vital signs are               
implemented. This particular model is just like the feedback mechanisms, since           
whenever the concentration of plasma increases, the lumped-parameter model [29] is           
modified which turn adjusts the individual parameters such as the heart rate, blood             
pressure and respiratory. 
Also, the Pulse mechanisms that link the different systems together are important in the              
modeling of the impact of multiple interventions (for instance, combining drug           
16 
infusions and ventilations) and also side effects of any interventions (for instance,            
interventions that only reduce blood pressure will lead to an increased heart rate). 
For additional flexibility, Pulse provides for patient variability, eight patients are           
included by default in the Physiology Engine's repository. These patients are           
characterized by a several parameters that can be modified through the patient files in              
order to tweak their baselines. The individual files are then utilized in the initialization              
of the computational. Only after the engine stabilizes can conditions such as chronic             
obstructive pulmonary disease and renal stenosis be applied to the patient. This process             
allows for analysis of different health conditions and treatments. Additionally, it is            
possible to add custom patients by creating new patient files and changing values for              
the different parameters within those files. 
3.3.1.2 The Common Data Model and Common Software Framework 
As earlier stated, the Pulse architecture was specifically designed for reduction of model             
development time and increase the usability of the engine in simulations through a             
modular, extensible software system that represents the human physiology. For these           
goals to be achieved, the Pulse architecture provides a Common Software Framework            
and a Common Data Model (CDM). 
The CDM specifies the data and the associated relationships with physiology           
simulation software in a dictionary-like format. The purpose of the Common Software            
Framework was to speed up the development time through the provision of a place to               
where common reusable algorithms can be implemented so as to ensure the basic             
functionality between programs is maintained. Consequently, the implementation of         
these common algorithms, simplifies reusability and validation which greatly speeds up           
model development time and ensure consistency in the results.  
A single interface for both inputs and outputs and also controlling the engine defines all               
the methods, based on the CDM. This is an interface that enables hardware and              
software developers to integrate Pulse into their respective application. It provides a            
standardized approach for interacting with Pulse. For instance, controls to injecting           
messages, output computed data values and advancing the engine time are provided. 
3.3.2. Modeling devices 
The CLA comprises of algorithms (assumed to be on a separate computer) and medical              
devices as stated previously. In the software framework these devices are abstract            
models of patient monitors and pumps. Interaction between these device components           
and Pulse is achieved by utilizing Pulse’s engine interface to directly observe the patient              
state and take appropriate action when needed. Similarly, the algorithm components           
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indirectly observer and effect action on patient state by interacting with the device             
components. 
3.3.2.1 Patient Monitors 
Patient monitors directly interact with the Pulse physiology engine to access the            
patient’s physiologic parameters. They can query these parameters at a rate whose            
equivalent sample period is a multiple of Pulse’s timestep of 20ms (i.e. the monitor can               
get a value from Pulse every 20·N ms where N = {1,2, ...}). At the same time, patient                  
monitors can output these physiologic variables to algorithms at a rate whose            
equivalent period is an integer multiple of its input sample period (i.e. the monitor can               
output values every inputPeriod·N where inputPeriod is how often it gets a value from              
pulse and N = {1, 2, ...}). Each one of these variables can be sampled and produced by                  
the monitor at different rates provided there is a valid relationship between the rate at               
which a variable is sampled from Pulse and its output rate. 
The variables passed to the algorithm from the patient monitors can either be unaltered              
values (i.e. as directly sampled from Pulse) or computed values (i.e. calculated from the              
input variables especially if the computed value requires multiple sequential unaltered           
values). For instance, we could model a monitor and computes the mean arterial             
pressure (MAP) from the systolic and diastolic blood pressures values in spite of the              
fact that it can we can directly obtain it from Pulse. Another example would be               
computing the value of stroke volume variation from a sequence of multiple stroke             
volume samples from Pulse. 
Inaccuracies in values can be modeled by adding deviations from the true values before              
they are output to the management algorithms. Though the current implementation           
does not support modeling inaccuracies, it is extensible to support the inaccuracies plus             
other behaviors. This should be in the future revisions as more cases are being              
developed. 
3.3.2.2 Physiology Management Algorithms 
These receive patient physiologic data from the monitors and query any of the             
accessible physiological parameters from the patient monitor at rate whose equivalent           
sample period is a multiple of the monitor’s output rate for that parameter (i.e.              
outputPeriodFromMonitor·N where N = {1, 2, 3...}). 
Whenever new data retrieved, the algorithm can decide to either make a decision based              
on the current input or delay the decision until enough samples are collected. The              
algorithm will send a command instructing the pump to take specific actions depending             
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on the on the decision. In addition, it is capable of making decisions in-between data               
arrivals since it has the opportunity to act in each time step of the simulation. 
Since the case study we are working with operates on the order of minutes, we               
currently do not model any issues of the algorithms executing on a computational             
platform. In future as we encounter cases with finer time scales, reasonable issues like              
computation time causing delayed decision making and interventions will be included. 
3.3.2.3 Pumps 
The pump conceptually delivers medicines and fluids into the patient at specific rates.             
Pumps can receive and execute instructions which include start, adjust, or stop            
infusions. Generally, they have a delay parameter that models computation time and            
time for mechanical components to adjust to a command from the algorithm. To model              
an ideal situation without physical effects this delay can be set zero. Inaccuracies such              
as adjusting the rate before the infusion is applied or during the application of infusion               
between adjustments can also be modeled. However, during our simulation the delays            
were modeled but the framework can be easily extended to support inaccuracies as             
well. 
3.3.3 Running a simulation 
The framework execution cycle relies on Pulse and because of this dependency, the             
system is advanced at the same speed as Pulse which updates at discrete time steps               
each representing 20ms of wall clock time in manner corresponding to a synchronous             
reactive computation model [30]. 
Through the simulation engine component, the framework controls scenario events          
specifically actions that happen to the patient independent of the CLA. As long as all               
other components have been initialized, the execution cycle of the simulation engine we             
built on top of Pulse is as follows: 
(1) Check for scenario events (including stop conditions) 
(2) Set up and apply any scenario events to patient 
(3) Execute one timestep of Pulse 
(4) Execute patient monitors 
(5) Execute algorithms 
(6) Execute pumps 
The update function in each of the CLA components is invoked on each timestep to act                
on the inputs at the point in time or not. There is also configuration file associated with                 
the system that allows the user to set and modify certain properties of the devices such                
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as the input and output rates, simulation running time, among others. The rate             
information from the configuration file is used to regulate when inputs and outputs are              
taken in and produced respectively. The benefit here, is that all changes to the              
properties in the file can be made without the need to recompile the code. 
3.3.4 Simulation Development 
Developing a simulation in our framework entails writing C++ code as well as putting              
information in a configuration file. The configuration settings are read and loaded into             
the CLA components using the provided methods. Inside these methods we perform            
basic error checking for example, confirming whether input and output out rates of the              
different models align. Provided there are no errors, an executable file is created in The               
folder where Pulse expects its executables to run from. That created executable is what              
runs the simulation. 
3.4 Case Study and Results 
We developed and simulated a case study simulation based on low blood pressure             
management in the ICU to demonstrate what the framework can do and the sorts of               
explorations we hope to avail users. 
In light of the discussion with Dr. John McIlwaine, DO, Medical Director for the Center               
for Telehealth and eICU at the Geisinger Health System about they manage low blood              
pressure cases, a greater part of what is presented here is specific to Geisinger, however               
it is in accordance with general practice at other medical institutions. For demonstration             
purposes and simplicity’s sake, several things were left out, in contrast to how it is               
actually done in hospitals. 
3.4.1 Clinical Scenario and General Strategy for Intervention 
Low blood pressure (hypotension) usually categorized as mean arterial blood (MAP)           
below 65mHg [31], [32] is not uncommon among patients in ICUs particularly those             
under post-operative care. It is crucial that MAP is regulated to ensure oxygen delivery              
to all organs in the body. One of the ways hypotension is managed is by infusing the                 
patient with both saline and a vasopressor drug such as norepinephrine meant to             
narrow the blood vessels. Concurrently, the doctors may attempt to determine and            
address its underlying cause during this process. 
The case study was centered around the intervention using norepinephrine infusion. A            
quasi-hybrid system shown in Figure 3.5 is a representation of procedures followed            
during the infusion process. The primary objective of hypotension management is to get             
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the MAP into a tolerable range (i.e., between 65 mmHg and 85 mmHg) and keep it                
within that range. 
The procedure comprises three parts. The first part involves the initial response to the              
hypotension where the patient is hit with the maximum allowed dose of the drug and               
fluid infusion is also started (the initial transition in Figure 3.5). In our case study this                
was maintained at a constant rate thus it was not included in Figure 3.5. The system                
then waits for the MAP to increase (in the state labeled “Wait for increase” in Figure                
3.5), checking every five minutes. 
The second part starts after the MAP has increased to or beyond the threshold (denoted               
by INC in Figure 3.5), which is usually around 100 mmHg. The dose is reduced to some                 
fraction of the maximum rate to avoid issues like high blood pressure and other side               
effects that can result from infusing a high dose of the drug. The dose is reduced until                 
the MAP stops rising and begins to drop. 
When the MAP drops to within the target range (denoted by MAP_MAX and             
MAP_MIN in Figure 3.5), the third part which ensures that MAP is maintained within              
this range (usually 65 mmHg and 85 mmHg) begins. Whenever the MAP falls below or               
goes above this range, the dose is increased and reduced respectively to counter this              
change. This process can continue for up to 24 hours or more, or until it is confirmed                 
that infusion of norepinephrine is no longer required. The MAP is consistently checked             
every 10 minutes between actions, however, when it falls below range (i.e. 65 mmHg)              
the frequency increases to every 5 minutes. 
3.4.2 Simulation Setup 
To explore the variability in both the CLA and the patients it must interact with, we                
examined two slightly different infusion protocols across a small patient population           
using the framework. We used three of the patients provided with Pulse. The three              
patients were selected because they were able to withstand the initial hemorrhaging            
used to create hypotension and the result intervention. The parameters tha Pulse uses to              
define these patients are shown in Table 3.1. For more information on how Pulse uses               
patient parameters to define different physiologies see [33]. 
We mimic postoperative hypotension in every patient by starting off with a lower             
baseline MAP and hemorrhaging them until the MAP falls to 70 mmHg, whereupon the              
protocol is triggered. For each patient, we ran the whole scenario for one hour of               
simulation time. 
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Figure 3.5.​ State machine representation of hypotension management algorithm (i.e. the 
norepinephrine infusion protocol). 
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Table 3.1.​ Patient Parameters 
Parameter 
Value for Patient 
Diana 
(ExtremeFemale)* 
Gus Hassan 
Sex Female Male Male 
Age (yr) 18 32 28 
Height (in) 54 70 72 
Weight (lbs) 90.2 190 185 
Body Fat Fraction 
(0 to 1) 
0.32 0.18 0.18 
Right Lung Ratio 
(0 to 1) 
0.5 0.525 0.525 
Systolic Blood 
Pressure Baseline 
(mmHg) 
90 90 90 
Diastolic Blood 
Pressure Baseline 
(mmHg) 
60 60 60 
Heart Rate Baseline 
(BPM) 
60 93 110 
Respiration Rate 
Baseline (1/min) 
12 14 18 
* See Pulse Patient Methodology [33] 
By parameterizing the infusion protocol (depicted in Figure 3.5) and tweaking one of             
the constants we were able to get two distinct strategies. That is, living all other               
parameters unaltered, we changed the only the percentage reduction in the dose in both              
algorithms. Table 3.2 shows the full infusion protocol parameters for both strategies. 
For simplicity in the software framework, the modeled patient monitor outputs MAP            
directly from Pulse as opposed to computing it from systolic and diastolic pressures like              
real monitors do. We also assume the value is accurate and does not introduce any               
error.   
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Table 3.2.​ Algorithm and General Simulation Parameters 
 
Parameter 
 
Symbol in 
Figure 3.5 
Value  
Units 
Algorithm 1 Algorithm 2 
Patient MAP at start - 70 mmHg 
Saline rate - 50 ml/hr 
Norepinephrine 
concentration 
- 16 µg/ml 
Maximum 
norepinephrine 
infusion rate 
MAXRATE 84 84 ml/hr 
Percentage reduction 
in norepinephrine 
infusion rate 
PERCENT 75 87.5 % 
MAP threshold to 
start reducing dose 
INC 80 80 mmHg 
Upper threshold of 
MAP target range 
MAP_MAX 80 80 mmHg 
Lower threshold of 
MAP target range 
MAP_MIN 75 75 mmHg 
 
The timing of monitor, algorithm, and pump in terms of how often data is acquired,               
output, or decided on is shown in Table 3.3. For the algorithm, we considered two               
scenarios in terms of how often it checked and decided on the MAP. The first is based                 
on information from Dr. McIlwane, which represents what clinicians do (we called the             
clinician behavior or the baseline), where the algorithm checks every 5 or 10 minutes              
depending on the algorithm state. This represents realistically what clinicians in the            
ICU are able to do given that they have multiple patients to check on as well as other                  
clinical tasks to perform. The second scenario has the algorithm checking once every             
minute, since this is typically the rate at which data is recorded into electronic health               
records [34], and represents the capability of a computer system being able to monitor              
more frequently than a human. 
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Table 3.3.​ Model Timing Parameters 
Parameters 
Value 
Units Clinician 
Behavior 
(Baseline) 
Computer 
System 
Behavior 
Monitor 
Sampling From 
Patient 
Rate 2 points/minute 
Period 30 secs 
Monitor Output 
to Algorithm 
Rate 1 points/minute 
Period 60 secs 
Algorithm check 
period  
 
 
 
Wait for increase state* 5 1 minutes 
After Wait for increase 
state  
(MAP > MAP_MIN)* 
10 1 minutes 
After Wait for increase 
state  
(MAP < MAP_MIN)* 
5 1 minutes 
Pump Infusion Action Delay 15 secs 
* See Figure 3.5 
3.4.3 Results 
3.4.3.1 Example Output 
Figures 3.6 shows plots of the various information extracted from an example            
simulation. The results are shown in such a way that they highlight how patient data is                
processed before it is presented on the monitor in a real patient monitor. For instance,               
the patient monitor has to convert the sensed input signals into digital values for further               
refinement before reporting them as the final observed values. The algorithm then sees             
a further sampled version of what the monitor observes. The patient data shown depicts              
the ‘ground truth’ MAP values coming directly from Pulse. In our simulation, the             
patient monitor samples data from Pulse every 30 seconds, and then reports it as              
observed data to the algorithm every minute. This shows that although a monitor can              
observe values at higher time resolutions, it may only report values to other systems at               
lower time resolutions so the algorithm’s view of the patient may not necessarily be the               
same as the monitor’s view of the simulated patients. The algorithm uses this             
information to decide when to send commands to pump to regulate infusion rates.             
25 
Though not noticeable in the figure, the pump has a delay of 15 seconds from when it                 
gets command till when the new infusion rate starts. 
Both the target MAP range and the period the CLA starts interacting are highlighted in               
all the plots to easily distinguish between the different parts of the scenario. From the               
results, we can also confirm that algorithm is indeed following the logic detailed in              
Figure 3.5 in line with the parameters in Table 3.2 by observing algorithm’s response to               
the to changes in MAP data. Although we do not show explicitly which of the three                
states the algorithm is in, the framework can be extended to capture and present this               
information as well. Regarding this particular situation, it can be seen in Figure 3.6 that               
the Algorithm 1 using the clinician behavior (baseline) timing successively got the            
patient (Hassan) from a state of low blood pressure after a few minutes and then into                
the targeted range within less 30 minutes from the start of the infusion process and was                
also able to maintain his MAP in that range for remaining part of the simulation.  
 
Figure 3.6.​ Result of running CLA with algorithm 1 parameters from Table 3.1  
with a single virtual patient. 
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3.4.3.2 Single Patient Multiple CLA Designs 
As mentioned earlier, one of the key advantages of this simulation framework is ability              
to explore the impact of designs along two dimensions: the impact of different design              
choices on a given patient, or the impact of patient variability on a given design. Both                
dimensions can be explored simultaneously to understand how different designs          
perform across the same patient population. Here, we look at the impact of different              
design choices on a single patient to get an initial sense of the kind of results we can                  
expect from a design space exploration. 
Figure 3.7 shows the results of of running the two different algorithms, and varying the               
timing behavior in each algorithm, with a given patient (Hassan). 
Timing 
Behavior 
Algorithm 1 Outcome Algorithm 2 Outcome 
Clinician 
(Baseline) 
  
Computer 
System 
Figure 3.7.​ Results of varying CLA behavior for a given patient (Hassan). 
The results show the advantage of simulation of over testing in biological systems             
(humans or animals). For each simulation, the CLA version starts with the exact same              
patient state. In addition, the only parameters that change are how often the CLA makes               
decisions on adjusting infusions based on the MAP and how much it reduces or              
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increases the norepinephrine infusion rate. All other parameters remain the same. We            
see four different patient physiology responses for the four different behaviors.  
Based on the results, it seems like for this simulation scenario, when adjusting infusions              
less often (clinician/baseline behavior), more aggressive rate changes (Algorithm 1)          
yield better results. However, when adjusting infusions more often (computer system           
behavior), less aggressive rate changes (Algorithm 2) yield better results. Although           
overall adjusting rates more often keeps the patient within the range more, the more              
aggressive rate changes cause the MAP to oscillate between the target boundaries            
whereas the less aggressive rate changes provide a smoother MAP response.  
For each case, we can dig deeper like in Figure 3.7 to see how the specific behavior of                  
the various entities may be contributing to the outcomes we observe. 
3.4.3.2 Full Design Space Exploration: Multiple Patients Multiple CLA Designs 
We can compare the four different CLA designs across the patient population as shown              
in Figure 3.8. Here we are only looking at the patient physiology outcome. However, for               
each patient, or each algorithm behavior we can examine the other outputs of the              
simulation to understand how the physiology outcome arises. It seems like all the CLA              
designs in this scenario have trouble keeping one patient in the desired range.             
Algorithm 2 with the computer system timing seems to do the best job of keeping the                
patients within the target range without too many oscillations in the MAP. 
For larger populations, we could use these visualizations to get a general sense of how               
the CLA does, or we could define metrics using techniques in (Asare dissertation) to              
define the performance of the CLA and compute these metrics to compare different             
designs. This ability to examine the performance of different CLA design choices across             
a patient population is the kind of capability we hope to provide to designers. The               
results from the software-only simulation part of the framework allow for rapid            
exploration of various designs in the early development stages, especially when no            
prototype of the system exists. The results here can inform the design of a prototype. In                
the later stages of the development when a prototype exists, however, it would be more               
desirable to be able to test the actual prototype with virtual patients. This capability is               
described in the next chapter. 
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Timing 
Behavior 
Algorithm 1 Outcome Algorithm 2 Outcome 
Clinician 
(Baseline) 
Computer 
System 
Figure 3.8.​ Results of varying CLA behavior for a patient population (Hassan, Gus, and Diana). 
Gus and Hassan behave similarly. The algorithms have trouble with is Diana. 
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Chapter 4 
System-in-the-Loop Simulation 
 
4.1 Motivation 
As mentioned at the end of the previous chapter, once a prototype of the system exists,                
it is more desirable to test the actual prototype with virtual patients. This provides the               
repeatability and controllability advantages of simulation, while increasing the realism          
of the environment in which the design is tested. This chapter describes the design and               
implementation of the part of our framework that allows for such real-time testing with              
real CLA prototypes. 
4.2 Architecture Overview and Design 
The conceptual architecture for this part of the framework is very similar to the              
software only part of the framework as shown in Figure 4.1. The main difference is that                
we now have to develop physical versions of the lines that connect all the pieces. In                
particular, on the device-patient interaction side, we have to design and develop            
physical systems for converting the information from Pulse into physical signals, that            
mimic signals from an actual human, that the patient monitor can capture and interpret,              
as well as for providing the right vascular resistance to the pump and converting              
measured fluid flow out of the pump into fluid flow into the virtual patient model. On                
the devices-algorithm side, we either have to leverage an existing CLA that can connect              
to existing medical devices to receive patient data from the monitor and control             
infusions on the pump, or develop our own CLA for testing. Fortunately, we have our               
own research prototype medical application platform on which CLA behavior can be            
developed to leverage. In addition to connecting all the various pieces, we also have to               
ensure that information flows in and out of the virtual patient to guarantee real-time              
behavior of the overall system.  
Similar to the case of the software-only simulation, what is most useful is the data that                
comes out of the simulation: not only the patient physiology data, but data about the               
behaviors of all the parts of the CLA. This means we must able to instrument the CLA                 
system and capture the data flowing between the devices and the algorithm as well as               
the algorithms internal state and decision-making.  
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Figure 4.1.​ Conceptual architecture of system-in-the-loop simulation framework for CLA-patient 
interactions 
4.3 Implementation 
4.3.1 openmedap Platform 
The research prototype medical application platform we used to implement the CLA for             
this work is openmedap [35]. It provides an ‘abstraction layer’ of the inner workings of               
the CLA system in order to enable the developers focus on building applications             
without the details of the devices being a major bottleneck. In addition, drivers for              
hardware devices such as the monitor and pump are provided to facilitate interaction             
and software development process. 
4.3.1.1 Platform Design 
Figure 4.2 shows the openmedap system architecture. From a connectivity or dataflow            
perspective, there are the medical devices that provide variables or abilities to act (e.g.              
infusing fluids) that the algorithm (or application) wants to make use of. The device              
drivers abstract away the specific devices and provide these variables and abilities to             
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act to applications through the device manager. The device drivers and manager work             
together to ensure that all pieces act safely when connectivity fails. 
 
Figure 4.2.​ ​openmedap architecture. 
Hardware 
From the abstraction layer perspective, at the lowest level is the hardware, which             
consists of the devices (in this case a monitor and pump), a host computer, one network                
switch, and 2 single-board computers (SBCs) that serve as the devices drivers (one per              
device). In this case, the SBCs are the BlackBone Black (BBB) [36]. Each of the BBB is                 
connected to a medical device and they host drivers of the attached devices to enable               
communication with the rest of the system and vice versa.  
Operating System and Network Services 
Above the hardware level is the operating system level that provides services that             
higher layers can access. All the hardware in the system run on The Ubuntu [37]               
operating system. The current version of openmedap runs on Ubuntu 16.04.6 LTS [38],             
which is a long term support version and will have maintenance updates until 2022.              
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Ubuntu was chosen as the operating system because of the software available to control              
more easily the operating system services that the platform needs. The main services             
are the domain name system (DNS), the dynamic host connection protocol (DHCP), and             
transmission control protocol/internet protocol (TCP/IP) deal with network connectivity         
and communication and allow us to connect the host computer to the BBB in ways the                
make the other layer so the platform run well. 
The host computer (which also acts as a router) manages all the data communication              
across the network. By using the dnsmasq tool the host PC is able to act as both DNS                  
and DHCP server. In other words, it can automatically assign, reclaim and manage the              
IP addresses centrally in a pool. The dnsmasq [39] tool is a lightweight infrastructure for               
small networks used for providing both Domain Name Server (DNS) and Dynamic            
Host Configuration Protocol (DHCP) server capabilities. Because computers in a          
network do not communicate in a human-like manner rather they use IP addresses that              
reference to a certain device in a network. The DNS server is used to automatically               
convert IP address like ‘192.168.xxx.xxx’ to their respective domain name such as            
‘example.com’ and vice versa. This enables the computer to be identified by a             
‘user-friendly’ name over the network.  
The DHCP server automatically assigns and distributes IP address to computers in a             
defined network range. It also packages other network parameters such as the subnet             
mask and the default gateway to each device in a network. Without the DHCP server,               
each computer added or removed from the network would require their IP addresses to              
be manually configured and reclaimed respectively. The DHCP server helps to solve            
this problem by performing dynamic assignment of IP addresses and returning IP            
addresses that are no longer in use to the DHCP pool which manages them centrally for                
reallocation to other DHCP-enabled clients. Since IP addresses are assigned          
dynamically, the same computer may not get the same IP address each time it joins.               
This is why the DNS is important, since it keeps track of which computer name (which                
doesn’t change) is assigned to which IP address. That way we can keep referring to the                
same computer by name even if its IP address changes each time it joins the network. 
Middleware: Robot Operating System (ROS) 
Above the operating system level is the middleware which handle messaging processes            
within the application and provides simpler mechanism for communication between          
the application, devices drivers, and the device manager than the lower-level operating            
system mechanisms. The current version of openmedap uses the robot operating system            
(ROS) [40] as its middleware because of the flexibility it provides as the system evolves               
over time. ROS is used to handles connections and communication between the            
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different software pieces (nodes) that make up the various endpoints of our system.             
These endpoints include the device drivers, the device manager, and the applications. 
 
Figure 4.3.​ ​Overview of ROS interactions showing two nodes named “Talker” and 
“Listener”. Master is the part of ROS the manages all the interactions between nodes. 
ROS is made up of various packages, libraries and tools that help it to perform its                
functionalities. Among these tools are communication processes referred to as nodes.           
ROS encourages modularity by ensuring that application is separated into components           
where each performs a specific task. These components are referred to as nodes. In the               
current setup, the endpoints (pump, monitor and the computer hosting algorithm ) are             
the nodes. 
In order for these nodes to communicate, messages are published (e.g. by Talker node)              
through a particular channel (or topic). The message are received by all the nodes (e.g.               
Listener node) subscribing to that topic. The setup is shown in figure 4.3. The peer-to               
peer model used by ROS to enable nodes to either transmit or receive data known as the                 
publish/model. 
Before establishing a peer to peer communication, the nodes need to register with the              
‘Master’. The Master is mainly concerned with registration of names and any other             
information pertaining to the nodes on the network. This is useful because it ensures              
that all the nodes can easily locate each other, otherwise, it would be impossible for               
them to communicate. It is usually invoked by issuing ‘roscore’ command in the             
terminal.  
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Furthermore, ROS supports inter-process messaging between components that are         
distinct from each other and are operating in different programming languages that are             
different from each other. This feature greatly simplifies communication between          
components in our system which are built in different languages (i.e., python and C++              
components). 
4.3.1.2 Example Applications 
Openmedap comes with example applications that demonstrate its capabilities for          
connecting to medical devices as well as for development software that makes use of              
these medical devices. There are three current example applications: an application that            
displays the heart rate and oxygen saturation from a Philips Intellivue patient monitor             
(patient monitor demo), one that starts, adjusts, and displays infusions from a            
BodyGuard 121 Twins infusion pump developed by CME America (pump demo), and            
an application that reacts to data coming from the Philips monitor by adjusting the              
infusion rate on the CME pump (closed-loop demo). 
Patient Monitor Demo 
This demo application demonstrates the communication management capabilities of         
openmedap and also its ability to send messages from a device to an application for               
display. The application connects to a receives information from a device driver for the              
Philips Intellivue patient monitor (in this case an MP50).  
On startup, the application checks to see if the device is available for connection. If it is                 
not, the application indicates this and does not allow the user to start the monitoring.               
Once the device is detected, the connection is indicated as green and the user can now                
start the monitoring. At any time during the monitoring, if the device is disconnected,              
the user is alerted. Once the user acknowledges receipt of the alert, the application goes               
back to the start screen and indicates in red or yellow that the driver or device                
connection is lost respectively. 
Pump Demo 
The Pump Demo application provides an interface for users interact with a pump (in              
this case the CME America BodyGuard 121 Twins pump). Like the Patient Monitor             
Demo, this application also displays the device and driver connection status on startup,             
and monitors this connection while the pump is running in order to alert the user if the                 
connection is lost while the pump is running. The application lets the user initializes              
pump with specific setting parameters (i.e. bag volume and infusion rate) provided the             
pump is connected. While the pump is running, it displays the current rate and volume               
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left to be infused. The user can also adjust the infusion rate while the pump is running.                 
They can also pause, resume, or completely stop the infusion. 
Closed-Loop Demo 
The Closed-Loop Demo application demonstrates automated monitoring and infusion.         
The application monitors the heart rate and oxygen saturation and adjusts the pump             
infusion rate based on the heart rate value. Like the other two applications, it also               
continually monitors the connection to the two devices it works with and will alert the               
user and stop operation if a connection is lost. On startup, if both devices and drivers                
are connected, the user can start the application. Both the monitor values and the              
current state of the pump are displayed in the application while in action so the user                
can see what data the algorithm that adjusts infusions is acting on and what actions it                
takes. 
4.3.2 Time synchronization 
The CLA being a distributed system, it demonstrates the critical importance of clock             
synchronization. Typically, each device on the network runs off its own internal clock.             
This can be a major constraint for applications that depend on the clock accuracy and               
synchronicity in such systems (for instance the logging service on which the system             
may relies to record events in the order in which they occurred). To overcome this               
limitation the Network Time Protocol (NTP) was utilized. 
NTP is a standard computer protocol used throughout the internet as a means of              
achieving and maintaining synchronization of clock times among communicating         
computers and other network infrastructure in a network [41]. When computer devices            
communicate in a network, the timestamps of the data packets, time difference, and the              
latency duration are encoded on the message and when the receiver gets the message, it               
decodes and reads the information. NTP is an application layer protocol and in its              
implementation, NTP comprises the following phases, network time servers (NTS),          
NTP stratum, precision oscillators, and the client software. 
A network time server is a device (which in our case is the host computer) that receives                 
precise time from an external hardware clock and provides the accurate timing            
reference to the network. This accurate time is maintained internally and passed to the              
network time clients upon request. The network time server then provides a time             
reference to all devices in a network. NTP stratum is a series of hierarchical protocols.               
Each stratum is synchronized to the level above in the hierarchy. At the top level, there                
is a stratum 1 server which provides an accurate time reference to an external hardware               
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clock. The precision oscillators are used to provide time reference backup, examples            
include rubidium and an oven-controlled crystal oscillator. 
In practice, the NTP works in a request and response format where the NTP clients               
(beaglebones connected to the CLA components in our case) initiate a request to the              
time servers then it synchronizes it’s time to match the time on the server clock. The                
client is also able to calculate the link delay (latency) and its local offset (The absolute                
difference on the time value of the two clocks). It includes a pair of peer/poll processes                
for each reference clock or remote server used as a synchronization source. Packets are              
exchanged between the client and server using the on-wire protocol. The poll process             
sends NTP packets at intervals ranging from 8 s to 36 hr. The peer process receives NTP                 
packets and performs the packet sanity tests and the results of various access control              
and security check.  
Once synchronized, the client updates the clock about once every 10 minutes, usually             
requiring only a single message exchange. This transaction occurs via the User            
Datagram Protocol on port 123. 
The architecture for our NTP implementation is shown in Figure 4.3. 
Figure 4.3​.​ ​NTP  Architecture 
 
4.3.3 Instrumenting the CLA 
To be able to gather and collect data generated during simulations, some form of              
instrumentation was required. We developed a logger using the python. The logger            
records its data in CSV files. The recorded data contains all the events as well as the                 
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time at which they occurred during the simulation run. For instance in case of the               
physiology algorithm, the logger was able to capture the invasive blood pressure (IBP)             
values received from monitor on each time step, instructions that were sent to the              
infusion pump and other useful things which the user can analyze at a later point. The                
information captured is formatted in such a way that it can easily understood by the               
user. Figure 4.4 is a snippet showing the kind of formatted messages captured by the               
logger. Each instance of an event has the date, time, module name, logging severity              
level and the message. 
 
Figure 4.4.​ Snippet of logged messages 
4.3.4 Simulating Pulse Virtual Patients in Real-Time 
Pulse drives the entire execution process and as stated earlier, it can execute and              
produce outputs relating to the patient’s state at a rate of 50Hz by default. Since we are                 
using actual medical devices in this case, it is desirable that we run simulations in real                
time in order to try to mimic what actually happens in a clinical setting in real time                 
(specifically the ICU in our case). The synchronization process which involves sending            
the data from Pulse to monitor and initiating infusion is handled within the Prosim              
driver update method. Figure 4.5 shows how the synchronization between Pulse and            
the system clock time is achieved. N and t denote the total number of simulation steps                
and time between updates in the real world respectively (put simply,  
N = TotalSimulationTime/t, where t = {1,2,3…}). The steps involved in this process are              
as follows. 
(1)   Pulse Advance time 
(2)   Send physiologic variables to monitor 
(3)   Initiate infusions 
(4)   Wait until next update 
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Figure 4.5.​ Pulse to real-time synchronization 
The Pulse Advance time should be equal to the update period t in real world. The time                 
information is set by the user in the configuration file and for the case study the update                 
period was set to 1s. Figure 4.6 is an excerpt of the recorded data demonstrating a 1                 
second interval between each timestep in a real-time simulation. We analyze the            
real-time performance of the system in ​Section 4.4 where we present and discuss the              
results of evaluating this realtime framework based on the case study introduced in             
Section 3.4​. 
Figure 4.6​ Snippet of recorded real-time durations 
4.3.4.1 Virtual Patients with Simulated Devices in Real-Time 
Before committing to a setup with real medical devices, we propotyped a scenario             
where everything operated in real-time but with simulated devices. Where the virtual            
patient interacts with the openmedap platform and openmedap-based algorithm         
through a simulated pumps and monitors. This allows us to identify any issues in the               
real-time architecture while eliminate issues from the devices themselves as possibility.           
It also serves as a useful real-time testing framework for those who may not have access                
to the medical devices. 
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Pulse which implements the virtual patient needs a way to interact with the             
openmedap-based CLA. We rely on ROSBridge [42] to to achieve this functionality as             
shown in Figure 4.7. ROSBridge is a collection of different ROS packages that enable              
non-ROS applications (like our patient simulation in Pulse) to interact with ROS            
applications. This package allows non-ROS apps to create ROS channels, through which            
data can be published and received as JSON strings using ROSBridge API.  
 
Figure 4.7.​ Conceptual picture of Pulse interacting with openmedap-based CLA algorithm in 
real-time using  the simulated devices.  
The simulated monitor publishes to the ‘/monitor’ channel which the openmedap-based           
algorithm subscribes to in order receive patient related information. The data published            
on this channel includes both the systolic (​ABP​sys​) and the diastolic (​ABP​dias​) blood             
pressure values. The algorithm uses this data to compute the mean arterial blood             
pressure (MAP) (using the equation 4.1), on which it bases to make decisions (i.e., send               
commands to pump). The value obtained from the formula is only an estimate of the               
true MAP value, which is more accurately derived using the area under the curve of the                
arterial blood pressure waveform. 
 ​ ​   (4.1)APM = 31 · ABP sys + 32 · ABP dias   
40 
The pump provides a ‘/pump’ channel where it receives action commands from the             
algorithm. Pulse intercepts the messages from the algorithm to the pump and            
implements the action that the algorithm wants in the simulation. 
4.3.4.2 Virtual Patient with Real Devices in Real-Time 
In contrast to the simulated devices setup, here the virtual patient interacts with the              
openmedap platform via real devices. The architecture is shown in Figure 4.8 
 
Figure 4.8.​ Conceptual picture of Pulse interacting with openmedap-based CLA algorithm 
using real devices. 
In order for Pulse to interact with the monitors we use The Fluke Biomedical Prosim 8                
patient vitals simulator hardware [43]. The Prosim 8 hardware is a device that converts              
the physiologic values from Pulse into physical signals that can be detected by standard              
patient monitors. Pulse communicates with the Prosim 8 hardware via a driver that we              
developed. 
Currently, Pulse with the pump via ROSBridge. We are currently working on a solution              
that does not require intercepting the messages to adjust infusion rates to the pump.              
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This would make the interface between the virtual patients and the medical devices             
(patient monitor and pump) fully agnostic to the specific devices used. 
4.4 Case Study and Results 
We repeated the scenarios using the clinician (baseline) timing behavior of the            
algorithm that were run in the software-only framework in the real-time framework            
both for the case with simulated devices and for the case with real devices. These               
allowed us to compare how the results change as we increase the realism of the test                
environment from low level for realism in the software-only simulations to the higher             
level of realism in system-in-the-loop simulation with real devices. We worked with the             
clinician baseline because that is the scenario against which we can validate the data in               
the future once we have access to clinical data. 
4.4.1 Real-Time Performance 
In order for this part of the framework to be useful, it must be able to operate in                  
real-time on reasonable computing resources. Earlier, in Section 4.3.4, we showed a            
snippet of the logged timing data to show that the system updates once every second as                
intended. For our case study, updates once every second was chosen because this is the               
minimum rate at which monitors and pumps are able to respond over their respective              
computer interfaces. It also represents the order of magnitude of time at which humans              
who interact with the system are able to reasonably respond. 
The specification for the computer on which virtual patient was run for all real-time              
experiments is shown in Table 4.1. 
Table 4.1. ​Virtual patient computer specifications 
Parameter Value 
Brand Lenovo ThinkCentre M83 Tiny 
CPU Intel® Core™ i5-4590T CPU @ 2.00GHz (4 cores)  
RAM 15.6 GiB 
Operating System Ubuntu 16.04 LTS 
 
We found in experimentation that capturing the infusion information from the pump            
works consistently when there is a 0.2s timeout on reading the information. In             
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measurements, we found that this timeout dominates the infusion update. For updating            
the Prosim 8 hardware, we send four different commands and wait 0.1s between             
sending commands. In measurements, we found that this waiting time dominates the            
overall updates to the Prosim 8 and measured consistently that the Prosim 8 hardware              
took 0.4s to update. This means the remaining 0.4s in the update time is what Pulse has                 
to work with. Figure 4.9 shows how long each 1s step of the simulation took to update                 
in Pulse over the course of each of the 12 one-hour real-time simulations. Figures 4.10               
and 4.11 shows the distribution of Pulse update time values for each simulation for the               
simulated devices and real devices cases respectively. 
In all cases, none of the simulations exceed the 0.4s bound at any point during the                
simulation. Most of the simulations stay around the 0.2s mark or less.  
 
Figure 4.9. ​Pulse time to simulate 1s of simulation time at each point in the real-time 
simulation for 12 different simulations. The blue line indicates the maximum allowed time.  
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 Patient Algorithm 1 Algorithm 2 
Diana 
Gus 
Hassan 
Figure 4.10. ​Distribution of Pulse time to simulate 1s of simulation time  
for the simulated devices case. The blue line indicates the maximum allowed time.  
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Patient Algorithm 1 Algorithm 2 
Diana 
Gus 
Hassan 
Figure 4.11. ​Distribution of Pulse time to simulate 1s of simulation time  
for the real devices case. The blue line indicates the maximum allowed time.  
4.4.2 Comparison of Patient Outcomes Across Simulation Types 
One simple comparison of the difference in behavior of the different simation types             
(software-only, real-time with simulated devices, real-time with real devices), is to           
examine the ‘ground truth’ MAP of the virtual patient for the same simulation scenario.              
If there is any significant disagreement between values across the simulations, we can             
use the other logged data to examine the behavior of other parts of the system using the                 
45 
data that is logged. Figure 4.12 shows the plot of the MAP for all three simulation types                 
for each patient under the baseline timing behavior of the algorithm. For these plots the               
results mostly agree with the exception of the versions with simulated devices for Gus              
and Hassan. We can dig deeper into these specific simulations to understand why the              
differences arise. 
Patient Algorithm 1 Outcome Algorithm 2 Outcome 
Diana 
Gus 
Hassan 
Figure 4.12.​ Comparison of patient outcomes across  
simulation types (baseline timing behavior). 
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Figure 4.13 shows the case of Gus with the simulated devices in real-time under              
algorithm 1 indicating the algorithm’s view of the patient’s MAP, as well as the ‘ground               
truth’ patient MAP. Remember from equation 4.1 in Section 4.3.4.1 that for the             
simulated devices case, the algorithm estimates the MAP from the systolic and diastolic             
arterial pressures reported by the simulated monitor, and that this equation is an             
approximation that does not account for the area under the curve of the arterial              
pressure waveform which is the more accurate MAP measure. You can see in this              
Figure that the algorithm consistently underestimates the MAP which causes it to            
increase the norepinephrine infusion although the actual MAP is within range at            
around the 53-minute mark.  
 
Figure 4.13.​ Result of simulating Gus in real-time under algorithm 1 with baseline timing 
behavior using the simulated devices.  
The reason why the increase in infusion is not immediate is because around the              
33-minute mark it changes the infusion to continue to ensure the decline of the MAP               
and waits 10 minutes to check the MAP again, as spelled out in the algorithm               
description in Section 3.4.1 and shown in Figure 3.5. At the 43-minute mark, the              
47 
algorithm realizes that the MAP has reduced below the intended decline threshold and             
switches states to keeping the MAP within the target range. While switching states, the              
algorithm does not adjust the infusion. This is the specified this behavior in Section 3.4.1               
and Figure 3.5. After the state switch, the algorithm waits another 10 minutes before              
checking the MAP to adjust infusions. At the 53-minute mark it estimates that the MAP               
is below the target range so it increases the infusion. It then waits 5 minutes as                
specified, and then adjusts the infusion again at the 58-minute mark. 
The real devices simulation as shown in Figure 4.12 does not have this problem because               
it uses the MAP value from the patient monitor which computes the MAP from the               
arterial waveform. 
The real devices simulation would sometimes encounter problems since it was           
operating on the full openmedap platform. Figure 4.14 shows one such case (Hassan             
under algorithm 1 with the baseline timing behavior) where the real-time simulation            
does not agree with the software-only simulation. Upon further examination in Figure            
4.15, we can see that the algorithm stops receiving MAP values from the patient              
monitor around the 23-minute mark due to a lost connection to the monitor. Because of               
this, the algorithm is unable to react to the MAP values and change infusions, and the                
pump continues to infuse and the most recent rate that it was programmed to use by                
the algorithm, which results in the patient MAP behavior seen. 
 
Figure 4.14.​ Example of when real-time with real devices behavior deviates from 
software-only-simulation behavior for Hassan under algorithm 1 using baseline timing. 
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Figure 4.15. ​More in-depth view of algorithm behavior of real-time simulation shown in 
Figure 4.14. 
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Chapter 5 
Discussion and Conclusion 
 
In this thesis we presented the motivation for, design, and development of a framework              
to examine the efficacy of a physiological management strategies or systems in            
improving patient outcomes. To demonstrate the utility of the framework, we           
simulated and compared different algorithm strategies across a group of patients           
through both software-only only simulation and system-in-the-loop simulation. The         
software-only framework allowed us to quickly gain insights into which physiology           
management strategies or systems had the potential to result into better outcomes. The             
system-in-the-loop framework allowed us to understand better the behavior of different           
systems or strategies in a more realistic setting. In ​Chapter 4​, we showed how this               
framework and its logging mechanisms can be used to understanding deviations of            
real-time behavior from the software-simulation-only (more ideal) behavior. 
Although the framework is targeted at testing and validating technologies for managing            
physiology (CLAs), it actually serves as a good framework for also evaluating protocols             
that humans would apply manually. The case study in ​Chapter 3 illustrated this where              
we modeled the behavior of clinicians as a baseline. Since the real-time virtual patient              
system actually only interfaces directly with the medical devices, it cannot tell whether             
what is using the data from the monitor and adjusting the pump is a human or a                 
computer algorithm. This means we can also use that part of the system-in-the-loop             
framework to evaluate clinical protocols applied by humans. More importantly, since           
the CLA is an assistive tool and would be supervised by a clinician who can take over                 
treatment by working directly with the devices, the approach to the real-time            
simulation actually allows for evaluating the CLAs that are working with clinicians.            
This can prove to be a useful tool for learning about how clinicians might interact with                
CLAs and also for training clinicians to work with CLAs. 
The biggest limitation of the work is in the patient models and patient population.              
Although we were able to show proof-of-concept of the kinds of exploration a designer              
would be able to undertake, because of the limited set of patients in Pulse and also the                 
fact that the patients are not currently specifically designed to properly model patients             
undergoing surgery or in critical care in the ICU, were a not able to make any                
meaningful claims about the clinical relevance of our the results obtained from            
simulation. One important direction for future work is to improve the patient models to              
they can represent such physiologies and also to expand the number of different             
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patients so that more inter-patient variability can be explored, which would in turn help              
to increase the robustness of systems that leverage the simulation capabilities we            
provide for testing and validation. 
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